Metraipolis › archive › dc_e704a418fb70

Advances in therapeutic hybrid neuromodulation for Parkinson's disease — Europe PMC PMID:41502481

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41502481
DOI
10.1007/s13205-[numero omesso]-z
License (as archived)
solo-consultazione
Archived
2026-11-07T01:41:08.457Z
SHA-256 of the archived text
9bc004a1e8b3226beec7ec480f0d1548aa429b951f453b50837b1e85946883b0
Stable URL of this page
https://metraipolis.com/documento/dc_e704a418fb70

How to cite

Advances in therapeutic hybrid neuromodulation for Parkinson's disease — Europe PMC PMID:41502481 — Europe PMC (en), https://europepmc.org/article/MED/41502481 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e704a418fb70 (Metraipolis archive dc_e704a418fb70, sha256 9bc004a1e8b3226beec7ec480f0d1548aa429b951f453b50837b1e85946883b0)
BibTeX
@misc{dce704a418fb70,
  title = {Advances in therapeutic hybrid neuromodulation for Parkinson's disease — Europe PMC PMID:41502481},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41502481},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e704a418fb70; sha256 9bc004a1e8b3226beec7ec480f0d1548aa429b951f453b50837b1e85946883b0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41502481. Agents can read the archived copy with the MCP tool read_document.